MDT

101.5

+1.85%↑

A

139.72

+1.42%↑

VEEV

225.69

+2.98%↑

HQY

87.23

+3.21%↑

NEOG

10.01

+4.6%↑

MDT

101.5

+1.85%↑

A

139.72

+1.42%↑

VEEV

225.69

+2.98%↑

HQY

87.23

+3.21%↑

NEOG

10.01

+4.6%↑

MDT

101.5

+1.85%↑

A

139.72

+1.42%↑

VEEV

225.69

+2.98%↑

HQY

87.23

+3.21%↑

NEOG

10.01

+4.6%↑

MDT

101.5

+1.85%↑

A

139.72

+1.42%↑

VEEV

225.69

+2.98%↑

HQY

87.23

+3.21%↑

NEOG

10.01

+4.6%↑

MDT

101.5

+1.85%↑

A

139.72

+1.42%↑

VEEV

225.69

+2.98%↑

HQY

87.23

+3.21%↑

NEOG

10.01

+4.6%↑

Search

ICU Medical Inc

Aperta

SettoreSettore sanitario

159.58 3.69

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

151.75

Massimo

159.8

Metriche Chiave

By Trading Economics

Entrata

-39M

-3.4M

Vendite

-12M

537M

Margine di Profitto

-0.632

Dipendenti

15,000

EBITDA

-40M

67M

Raccomandazioni

By TipRanks

Raccomandazioni

Acquista

Previsioni per 12 mesi

+13.23% upside

Dividendi

By Dow Jones

Utili prossimi

26 feb 2026

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

822M

3.9B

Apertura precedente

155.89

Chiusura precedente

159.58

Notizie sul Sentiment di mercato

By Acuity

34%

66%

111 / 360 Classifica in Healthcare

Punteggio Tecnico

By Trading Central

Fiducia

Very Strong Bullish Evidence

ICU Medical Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

21 gen 2026, 23:49 UTC

I principali Market Mover

Karman Space & Defense Shares Rise as 2026 Forecast Tops Analyst Estimates

21 gen 2026, 21:12 UTC

I principali Market Mover

Automaker Stocks Rise After Trump Calls Off European Tariffs

21 gen 2026, 21:00 UTC

Acquisizioni, Fusioni, Takeovers

Deutsche Borse Group to Acquire Allfunds for $6.19 Billion

21 gen 2026, 20:29 UTC

I principali Market Mover

Chip Makers Gain After Trump Calls Off European Tariffs

21 gen 2026, 20:04 UTC

I principali Market Mover

Apparel, Footwear Stocks Rise After Trump Calls Off European Tariffs

21 gen 2026, 23:48 UTC

Discorsi di Mercato

Nikkei May Rise as U.S.-Europe Tensions Ease -- Market Talk

21 gen 2026, 23:34 UTC

Discorsi di Mercato

Gold Falls Amid Easing U.S.-Europe Tensions Over Greenland -- Market Talk

21 gen 2026, 22:39 UTC

Utili

Schwab's Profit Jumps on Surge in Brokerage Activity -- 2nd Update

21 gen 2026, 21:50 UTC

Discorsi di Mercato

Financial Services Roundup: Market Talk

21 gen 2026, 21:50 UTC

Discorsi di Mercato

Basic Materials Roundup: Market Talk

21 gen 2026, 21:35 UTC

Acquisizioni, Fusioni, Takeovers

Tesla Stock In Focus as Musk and Ryanair Chief Trade Insults. Should Investors Worry? -- Barrons.com

21 gen 2026, 21:19 UTC

Utili

Charles Schwab Earnings Miss Estimates. The Stock Is Rising Anyway. -- Barrons.com

21 gen 2026, 20:45 UTC

Acquisizioni, Fusioni, Takeovers

Deutsche Borse Group to Acquire Allfunds for $6.19B

21 gen 2026, 20:36 UTC

Discorsi di Mercato

U.S. Natural Gas Posts Back-to-Back Hefty Gains -- Market Talk

21 gen 2026, 20:31 UTC

Discorsi di Mercato

Oil Settles Higher With Support From Heating Fuel -- Market Talk

21 gen 2026, 20:27 UTC

Acquisizioni, Fusioni, Takeovers

Deutsche Boerse Expects Combined Company Will Be Able to Achieve Annual Run Rate Pretax Cost Synergies of About EUR60M

21 gen 2026, 20:27 UTC

Discorsi di Mercato

Global Forex and Fixed Income Roundup: Market Talk

21 gen 2026, 20:27 UTC

Discorsi di Mercato

Was It a 'TACO' Event? -- Market Talk

21 gen 2026, 20:26 UTC

Acquisizioni, Fusioni, Takeovers

Deutsche Boerse Has Received Irrevocable Undertakings in Support of Acquisition in Respect of About 48.9% of Allfunds Issued Share Capital Excluding Treasury Shares

21 gen 2026, 20:23 UTC

Acquisizioni, Fusioni, Takeovers

Deutsche Boerse: Allfunds Stockholders to Receive EUR8.80/Shr, Including Cash, Stock and Permitted Dividend

21 gen 2026, 20:21 UTC

Acquisizioni, Fusioni, Takeovers

Deutsche Boerse: Agreement Values Allfunds at About EUR5.3B

21 gen 2026, 20:19 UTC

Acquisizioni, Fusioni, Takeovers

Deutsche Boerse Group Agrees to Buy Allfunds

21 gen 2026, 20:08 UTC

Utili

Prologis Revenue Climbs as Warehouse Demand Rebounds -- Update

21 gen 2026, 20:03 UTC

Discorsi di Mercato

Precious Metals Drop After Trump Posts About Greenland Deal -- Market Talk

21 gen 2026, 19:51 UTC

Discorsi di Mercato

Treasury Markets React to Trump's Softer Tone About Greenland -- Market Talk

21 gen 2026, 19:43 UTC

Discorsi di Mercato

U.S. Ethanol Production Expected to Slip -- Market Talk

21 gen 2026, 19:31 UTC

Discorsi di Mercato

Gold Settles at Fresh All-Time High -- Market Talk

21 gen 2026, 19:24 UTC

Utili

Johnson & Johnson Tops Earnings Estimates and Issues a Solid Outlook. The Stock Falls. -- Barrons.com

21 gen 2026, 19:10 UTC

Discorsi di Mercato

Mexican Inflation Seen Picking Up in Early January -- Market Talk

21 gen 2026, 18:57 UTC

Discorsi di Mercato

DAVOS: IBM CEO Krishna Says World Is More Volatile Now -- Market Talk

Confronto tra pari

Modifica del prezzo

ICU Medical Inc Previsione

Obiettivo di Prezzo

By TipRanks

13.23% in crescita

Previsioni per 12 mesi

Media 173.5 USD  13.23%

Alto 175 USD

Basso 172 USD

Basato su 3 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per ICU Medical Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

3 ratings

2

Acquista

1

Mantieni

0

Vendi

Punteggio Tecnico

By Trading Central

137.16 / N/ASupporto e resistenza

A breve termine

Very Strong Bullish Evidence

A termine intermedio

Bullish Evidence

A lungo termine

Strong Bearish Evidence

Sentiment

By Acuity

111 / 360 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Prove rialziste

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sotto la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo ICU Medical Inc

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride and sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 and Plum Duo brands; ambulatory and syringe infusion hardware products; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform; LifeShield and PharmGuard medication infusion safety software; hemodynamic monitoring products; anesthesia systems and devices, breathing circuits, ventilation, respiratory, and specialty airway products; temperature management solutions; anesthesia/pain management trays and components; and professional services. The company's customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, including outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is based in San Clemente, California.
help-icon Live chat